Price T Rowe Associates Inc AVADEL PHARMACEUTICALS PLC Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
Number of Shares
36,673
Previous 30,228
21.32%
Holding current value
$386,000
Previous $397,000
2.77%
% of portfolio
0.0%
Previous 0.0%